Early Lung Disease in Cystic Fibrosis
Transcript of Early Lung Disease in Cystic Fibrosis
![Page 1: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/1.jpg)
Early Lung Disease in Cystic Fibrosis
Sarath Ranganathan
![Page 2: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/2.jpg)
![Page 3: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/3.jpg)
![Page 4: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/4.jpg)
![Page 5: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/5.jpg)
Defective CF gene
Defective/deficient CFTR
Bronchial obstruction
Infection
Bronchiectasis
Inflammation
Abnormal airway surface milieu
![Page 6: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/6.jpg)
UK cystic fibrosis population. Proportion of a) males and b) females of each 3-yr cohort surviving until 2003. : 1968–1970; : 1971–1973; : 1974–1976; : 1977–1979; : 1980–1982; : 1983–1985; : 1986–1988; •: 1989–1991; : 1992–1994.
Survival in UK CF CohortsDodge et al Eur Respir J 2007
![Page 7: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/7.jpg)
100908070605040
400
300
200
100
0
Prior LRI
No prior LRI
Control
Length (cm))
FEV 0
.4(m
L)
FEVFEV0.40.4 vs length in healthy infants and infants with CF vs length in healthy infants and infants with CF with and without prior lower respiratory with and without prior lower respiratory illnessillness
Ranganathan et al Lancet 2001Ranganathan et al Lancet 2001
![Page 8: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/8.jpg)
![Page 9: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/9.jpg)
Median FEV1 has improved more than 10 percentage points at all ages from 6 to 30 since 1990.
4 0
60
80
100
6 8 10 12 14 16 18 2 0 2 2 2 4 2 6 2 8 30
Perc
ent P
redi
cted
Age (Years)
Median FEV1 Percent Predicted vs. Age, 1990 and 2009
1990 2009
![Page 10: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/10.jpg)
The early surveillance program
![Page 11: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/11.jpg)
Early Surveillance Program
![Page 12: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/12.jpg)
Early Bronchiectasis detected by surveillance CT Pillarisetti et al Respirology 2010;6:1009‐11
![Page 13: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/13.jpg)
How early does disease occur?
![Page 14: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/14.jpg)
Prevalence of symptoms, infection, inflammation and structural changes at diagnosis
Sly et al Am J Respir Crit Care Med 2009;180:146‐142
Number studied 57
Age 3.6 months
Respiratory symptoms 9 (16%)
Bacterial infection 12 (20%)
Free neutrophil elastase 17 (30%)
Bronchial dilatation 11 (19%)
![Page 15: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/15.jpg)
• Lung structure
• Pulmonary infection
• Pulmonary inflammation
• Lung function
![Page 16: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/16.jpg)
Prevalence of BronchiectasisStick et al J Pediatr 2009;155:623-28
![Page 17: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/17.jpg)
Stick et al J Pediatr 2009;155:623-28
![Page 18: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/18.jpg)
Progression of structural changesMott et al. Thorax 2011
Subsequent scan
Initial scan
![Page 19: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/19.jpg)
• Lung structure
• Pulmonary infection
• Pulmonary inflammation
• Lung function
![Page 20: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/20.jpg)
Inflammation responses to individual organismsGangell et al Clin Infect Dis 2011;53:425‐432
Organism Number of BAL Significance
Aspergillus spp. 19 <0.001
Candida spp. 7 0.18
Escherichia coli 8 0.36
Enterobacter spp. 4 0.38
H. influenzae 12 0.017
Moraxella spp. 4 0.76
P. aeruginosa 29 <0.001
S. aureus 31 <0.001
Strep. pneumoniae 6 <0.001
Mixed Oral Flora 165 0.22
Multiple organisms 148 0.001
![Page 21: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/21.jpg)
• Lung structure
• Pulmonary infection
• Pulmonary inflammation
• Lung function
![Page 22: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/22.jpg)
Associations with BMI z‐score (n=42)Ranganathan et al Thorax 2011;66:408‐13
Coefficient 95% CI P‐value
Free NE ‐0.4 ‐0.8 to ‐0.1 0.02
S. aureus (25%)
‐1.0 ‐1.6 to ‐0.4 0.001
PsA
(10%)
0.04 ‐0.7 to 1.7 0.9
Anti-staphylococcal antibiotics (70%): better BMI z-score (p=0.01)
![Page 23: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/23.jpg)
• Lung structure
• Pulmonary infection
• Pulmonary inflammation
• Lung function
![Page 24: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/24.jpg)
Linnane et al. Am J Respir Crit Care Med 2008
![Page 25: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/25.jpg)
Linnane et al. Am J Respir Crit Care Med 2008
![Page 26: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/26.jpg)
Associations with lung function over timePillarisetti et al. Am J Respir Crit Care Med 2011
![Page 27: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/27.jpg)
Comparison of outcomes between infants with CF and controls at 3 months
Hoo et al. Thorax 2012
![Page 28: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/28.jpg)
Interventions aiming to prevent or arrest lung disease, rather than just damage limitation, must be the new paradigm for those
diagnosed with CF
![Page 29: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/29.jpg)
Evidence that we need to do betterWainwright et al. JAMA. 2011;306(2):163-171
![Page 30: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/30.jpg)
Conclusions• Lung disease (including structural changes) are common
at diagnosis.
• Lung function is diminished early and progression is related to lower respiratory infection
• ? Need to be more aggressive in preventing, detecting, eradicating and treating early S. aureus infection
• Early intervention studies essential to prevent structural changes and lung function decline.
• Can we target those at greatest risk of progression early in life?
![Page 31: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/31.jpg)
Acknowledgements
• United States Cystic Fibrosis Foundation
• National Health and Medical Research Council, Australia
• Cystic Fibrosis Australia
• National Institutes for Health
• Murdoch Children’s Research Institute
• Royal Children’s Hospital CF Trust
![Page 32: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/32.jpg)
PerthStephen StickPeter SlyElizabeth BaldingLuke BerryCindy Branch-SmithBarry ClementsTonia DouglasClara FooCatherine GangellLuke GarrattSamantha GroganGraham HallMilena JokicNick de KlerkAnthony Kicic
MelbourneSarath RanganathanColin RobertsonPhil RobinsonJohn CarlinRosemary CarzinoAnne-Marie EbdonAnne-Marie GibsonJo HarrisonEmily HartJohn MassieRoy Robins-BrowneBilly SkoricJohn Wong
www.arestcf.org
Ingrid LaingClair LeeKarla LogieLauren MottConor MurraySrinivas PoreddyLynn PriddisJudy ParkAnneli RobbshawLinda ShieldsShannon SimpsonErika Sutanto
![Page 33: Early Lung Disease in Cystic Fibrosis](https://reader033.fdocuments.us/reader033/viewer/2022052322/628a3ab7c58c2a5b5462d0ce/html5/thumbnails/33.jpg)
UBC, Uni of British Columbia; UNC, Uni of North Carolina; UWA, Uni Western Australia; WEHI, Walter & Eliza Hall Institute; ECFS CTN, European CF Society Clinical Trial Network; USCFF , US CF Foundation